Jiangsu Sihuan Bioengineering Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.104x

Jiangsu Sihuan Bioengineering Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Sihuan Bioengineering Co Ltd (000518) has a cash flow conversion efficiency ratio of 0.104x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.43 Million ≈ $5.92 Million USD) by net assets (CN¥388.58 Million ≈ $56.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu Sihuan Bioengineering Co Ltd (1998–2024)

Cash flow conversion efficiency of Jiangsu Sihuan Bioengineering Co Ltd from 1998 to 2024. This chart illustrates how Jiangsu Sihuan Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Jiangsu Sihuan Bioengineering Co Ltd for real-time trading data and today's change.

Jiangsu Sihuan Bioengineering Co Ltd Cash Flow Conversion Ratio Explained

Jiangsu Sihuan Bioengineering Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu Sihuan Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Sihuan Bioengineering Co Ltd ranked by their cash flow conversion efficiency. Also see 000518 market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Invesco California Value Muni Inc Tr
NYSE:VCV
0.018x
Berry Genomics Co Ltd
SHE:000710
-0.001x
Suzhou Sonavox Electronics Co. Ltd. A
SHG:688533
0.090x
Zhejiang Natural Outdoor Goods Inc.
SHG:605080
N/A
Colorlight Cloud Tech Ltd. A
SHE:301391
N/A
Sichuan Zhongguang Lightning Protection Technologies Co Ltd
SHE:300414
0.005x
Shenzhen Cotran New Material Co Ltd Class A
SHE:300731
0.025x
PLAYWAY SA
WAR:PLW
0.120x

Annual Cash Flow Conversion Efficiency for Jiangsu Sihuan Bioengineering Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Sihuan Bioengineering Co Ltd from 1998 to 2024. Review free cash flow generation of Jiangsu Sihuan Bioengineering Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥398.97 Million
≈ $58.38 Million
CN¥1.46 Million
≈ $213.84K
0.004x +15.25%
2023-12-31 CN¥512.78 Million
≈ $75.04 Million
CN¥1.63 Million
≈ $238.47K
0.003x -61.24%
2022-12-31 CN¥593.50 Million
≈ $86.85 Million
CN¥4.87 Million
≈ $712.02K
0.008x +3306.67%
2021-12-31 CN¥646.78 Million
≈ $94.64 Million
CN¥155.65K
≈ $22.78K
0.000x -99.84%
2020-12-31 CN¥685.05 Million
≈ $100.24 Million
CN¥100.23 Million
≈ $14.67 Million
0.146x +64.78%
2019-12-31 CN¥660.31 Million
≈ $96.62 Million
CN¥58.63 Million
≈ $8.58 Million
0.089x +152.93%
2018-12-31 CN¥642.80 Million
≈ $94.06 Million
CN¥22.57 Million
≈ $3.30 Million
0.035x +319.88%
2017-12-31 CN¥675.54 Million
≈ $98.85 Million
CN¥-10.79 Million
≈ $-1.58 Million
-0.016x -184.26%
2016-12-31 CN¥611.10 Million
≈ $89.42 Million
CN¥11.58 Million
≈ $1.69 Million
0.019x +108.47%
2015-12-31 CN¥608.69 Million
≈ $89.07 Million
CN¥-136.11 Million
≈ $-19.92 Million
-0.224x -903.20%
2014-12-31 CN¥721.59 Million
≈ $105.59 Million
CN¥20.09 Million
≈ $2.94 Million
0.028x +207.00%
2013-12-31 CN¥730.78 Million
≈ $106.94 Million
CN¥-19.02 Million
≈ $-2.78 Million
-0.026x -139.59%
2012-12-31 CN¥830.24 Million
≈ $121.49 Million
CN¥54.56 Million
≈ $7.98 Million
0.066x +199.90%
2011-12-31 CN¥915.76 Million
≈ $134.00 Million
CN¥20.07 Million
≈ $2.94 Million
0.022x -91.68%
2010-12-31 CN¥879.72 Million
≈ $128.73 Million
CN¥231.62 Million
≈ $33.89 Million
0.263x +229.06%
2009-12-31 CN¥712.38 Million
≈ $104.24 Million
CN¥57.00 Million
≈ $8.34 Million
0.080x -19.30%
2008-12-31 CN¥692.86 Million
≈ $101.39 Million
CN¥68.69 Million
≈ $10.05 Million
0.099x +207.07%
2007-12-31 CN¥833.76 Million
≈ $122.01 Million
CN¥26.92 Million
≈ $3.94 Million
0.032x +187.62%
2006-12-31 CN¥1.01 Billion
≈ $147.97 Million
CN¥-37.26 Million
≈ $-5.45 Million
-0.037x -581.72%
2005-12-31 CN¥1.00 Billion
≈ $146.76 Million
CN¥-5.42 Million
≈ $-793.25K
-0.005x -111.07%
2004-12-31 CN¥1.11 Billion
≈ $161.96 Million
CN¥54.05 Million
≈ $7.91 Million
0.049x -35.47%
2003-12-31 CN¥1.10 Billion
≈ $160.34 Million
CN¥82.91 Million
≈ $12.13 Million
0.076x -53.23%
2002-12-31 CN¥1.06 Billion
≈ $155.49 Million
CN¥171.92 Million
≈ $25.16 Million
0.162x +441.00%
2001-12-31 CN¥983.04 Million
≈ $143.85 Million
CN¥29.40 Million
≈ $4.30 Million
0.030x -74.00%
2000-12-31 CN¥204.83 Million
≈ $29.97 Million
CN¥23.56 Million
≈ $3.45 Million
0.115x +424.44%
1999-12-31 CN¥156.83 Million
≈ $22.95 Million
CN¥3.44 Million
≈ $503.34K
0.022x +152.29%
1998-12-31 CN¥104.29 Million
≈ $15.26 Million
CN¥-4.37 Million
≈ $-640.11K
-0.042x --

About Jiangsu Sihuan Bioengineering Co Ltd

SHE:000518 China Biotechnology
Market Cap
$458.00 Million
CN¥3.13 Billion CNY
Market Cap Rank
#12343 Global
#3544 in China
Share Price
CN¥3.04
Change (1 day)
-1.30%
52-Week Range
CN¥2.38 - CN¥4.54
All Time High
CN¥9.49
About

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded … Read more